Two major US pharmaceutical industry groups, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Association for Accessible Medicines (AAM), are appealing for new approaches in dealing with the problems that the COVID-19 pandemic has caused in the US pharmaceutical supply chain.
The AAM has reiterated its calls to move manufacturing back to the US, while PhRMA wants the US Department of...





